Pharma: Kendle Opens India Operations Center
June 24, 2010 (FinancialWire) — Kendle (NASDAQ: KNDL), a clinical research organization, said it has opened its new operations center in the Special Economic Zone of the Ahmedabad-Gandhinagar Knowledge Corridor in India.
According to the firm, the new SEZ center represents a strategic investment for Kendle and demonstrates the company's commitment to further invest in Asia/Pacific region. The center opened June 21.
Stephen Cutler, Kendle’s COO, said, "Growth in India is a key component of our strategy and will be very important to the future of Kendle." He said that the company’s expanded presence in Asia, and in India in particular, creates efficiencies in the clinical development process for Kendle’s customers worldwide.
The SEZ operations center focuses on delivery of clinical data management, medical writing, pharmacovigilance/safety, biostatistics/programming and other knowledge processing-related services.
Kendle's SEZ operations center will initially employ around 50 people at the site. The company said that the unit is expected to scale up to around 300 associates in the near term.
In addition to the new SEZ office, Kendle currently operates offices throughout the Asia/Pacific region in Ahmedabad and New Delhi, India; Beijing, Guangzhou, Hong Kong and Shanghai, China; Kuala Lumpur, Malaysia; Bangkok, Thailand; Manila, Philippines; Singapore; and Sydney and Melbourne, Australia.
Ohio-based Kendle International provides a range of early- to late-stage clinical development services for the world's biopharmaceutical industry.
Real-time, streaming research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://investrend.stocksmart.com/ss/html/hpcompany.html). Current valuation analysis research for companies and funds mentioned in FinancialWire(tm) news is available via the Investrend Research Syndicate (at http://www.valuengine.com/rep/searchsrep?pid=42&srchfor=).
FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public other companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (at http://www.financialwire.net/news-alerts/).
FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation from subject entities, companies, equities, or representatives thereof, for its news, opinions or distributions. Further disclosure is posted at the FinancialWire(tm) website (at http://www.financialwire.net/disclosures.php and http://www.financialwire.net/2010/04/23/safe-harbor/). Additional resources for investors are also accessible via the FinancialWire(tm) website (at http://www.financialwire.net/2010/04/23/investor-resources/). Contact FinancialWire(tm) directly via inquiries@financialwire.net.
Copyright © MMX, FinancialWire(tm); All rights reserved.
[hlmsmlh] [biomedphrm] [bsnnssb] [exxpndgbsns] [ntrntnlcmpnsbsnss] [nnddadn] [ntrntnlcmpnsbsnss] [btnwswntb]
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
